Figure 55.5. Antiestrogens being evaluated as potential breast cancer therapeutic agents or SERMs (raloxifene).

Figure 55.5

Antiestrogens being evaluated as potential breast cancer therapeutic agents or SERMs (raloxifene).

From: Chapter 55, Estrogens and Antiestrogens

Cover of Holland-Frei Cancer Medicine
Holland-Frei Cancer Medicine. 5th edition.
Bast RC Jr, Kufe DW, Pollock RE, et al., editors.
Hamilton (ON): BC Decker; 2000.
© 2000, BC Decker Inc.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.